JP2020531526A5 - - Google Patents
Info
- Publication number
- JP2020531526A5 JP2020531526A5 JP2020511322A JP2020511322A JP2020531526A5 JP 2020531526 A5 JP2020531526 A5 JP 2020531526A5 JP 2020511322 A JP2020511322 A JP 2020511322A JP 2020511322 A JP2020511322 A JP 2020511322A JP 2020531526 A5 JP2020531526 A5 JP 2020531526A5
- Authority
- JP
- Japan
- Prior art keywords
- carbon atoms
- trisubstituted
- disubstituted
- unsubstituted
- replaced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17187100 | 2017-08-21 | ||
| EP17187100.7 | 2017-08-21 | ||
| PCT/EP2018/072397 WO2019038214A1 (en) | 2017-08-21 | 2018-08-20 | QUINOXALINE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020531526A JP2020531526A (ja) | 2020-11-05 |
| JP2020531526A5 true JP2020531526A5 (enExample) | 2023-02-02 |
| JP7287951B2 JP7287951B2 (ja) | 2023-06-06 |
Family
ID=59677147
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020511322A Active JP7287951B2 (ja) | 2017-08-21 | 2018-08-20 | アデノシン受容体アンタゴニストとしてのキノキサリン誘導体 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11192899B2 (enExample) |
| EP (1) | EP3672951B1 (enExample) |
| JP (1) | JP7287951B2 (enExample) |
| KR (1) | KR20200043434A (enExample) |
| CN (1) | CN110944994B (enExample) |
| AU (1) | AU2018320672B2 (enExample) |
| BR (1) | BR112020003283A2 (enExample) |
| CA (1) | CA3073343A1 (enExample) |
| DK (1) | DK3672951T3 (enExample) |
| ES (1) | ES2964026T3 (enExample) |
| IL (1) | IL272638B2 (enExample) |
| SG (1) | SG11202001340VA (enExample) |
| TW (1) | TW201920123A (enExample) |
| WO (1) | WO2019038214A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020182929A1 (en) | 2019-03-13 | 2020-09-17 | Bayer Aktiengesellschaft | Substituted ureas and derivatives as new antifungal agents |
| JP7536036B2 (ja) * | 2019-03-28 | 2024-08-19 | シーストーン・ファーマスーティカルズ・（スージョウ）・カンパニー・リミテッド | Ａ２ａ受容体アンタゴニストの塩形態、結晶形態及びその製造方法 |
| CN118955502A (zh) * | 2020-07-23 | 2024-11-15 | 上海赛岚生物科技有限公司 | 一类具有激酶抑制活性的化合物 |
| WO2022058327A1 (en) | 2020-09-15 | 2022-03-24 | Bayer Aktiengesellschaft | Substituted ureas and derivatives as new antifungal agents |
| US20220127231A1 (en) * | 2020-10-27 | 2022-04-28 | Shilpa Medicare Ltd | Process for the prepartion of amifampridine phosphate |
| EP4059498A1 (en) * | 2021-03-16 | 2022-09-21 | Centre Hospitalier Universitaire Vaudois (CHUV) | Methods and compositions for treating conditions associated with hypermineralization |
| EP4351640A1 (en) | 2021-06-07 | 2024-04-17 | Ares Trading S.A. | Combination treatment of cancer |
| CN116514803A (zh) * | 2022-01-21 | 2023-08-01 | 上海赛岚生物科技有限公司 | 一种激酶抑制剂的盐晶型和自由碱晶型 |
| CN121270522B (zh) * | 2025-12-10 | 2026-03-17 | 四川大学华西医院 | 吲唑-苯并三唑-吡唑结构衍生物及其制备方法和应用 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4207554A (en) | 1972-08-04 | 1980-06-10 | Med-El Inc. | Method and apparatus for automated classification and analysis of cells |
| US4125828A (en) | 1972-08-04 | 1978-11-14 | Med-El Inc. | Method and apparatus for automated classification and analysis of cells |
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| CA2242425C (en) | 1996-02-13 | 2006-07-18 | Zeneca Limited | Quinazoline derivatives as vegf inhibitors |
| NZ331191A (en) | 1996-03-05 | 2000-03-27 | Zeneca Ltd | 4-anilinoquinazoline derivatives and pharmaceutical compositions thereof |
| GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
| US6579868B1 (en) | 1998-01-05 | 2003-06-17 | Eisai Co., Ltd. | Purine derivatives and adenosine A2 receptor antagonists serving as preventives/remedies for diabetes |
| GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
| GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
| WO2001002400A1 (en) | 1999-07-02 | 2001-01-11 | Eisai Co., Ltd. | Fused imidazole compounds and remedies for diabetes mellitus |
| BR0111230A (pt) | 2000-05-31 | 2003-06-10 | Astrazeneca Ab | Composto, e, uso e processo para a preparação do mesmo |
| KR20030014425A (ko) | 2000-07-07 | 2003-02-17 | 앤지오젠 파마슈티칼스 리미티드 | 혈관 손상제인 콜치놀 유도체 |
| EE200300015A (et) | 2000-07-07 | 2004-10-15 | Angiogene Pharmaceuticals Limited | Kolhinooli derivaadid kui angiogeneesi inhibiitorid |
| WO2004089942A2 (en) | 2001-10-02 | 2004-10-21 | Acadia Pharmaceuticals Inc. | Benzimidazolidinone derivatives as muscarinic agents |
| JP2005516917A (ja) | 2001-12-12 | 2005-06-09 | アメリカ合衆国 | 細胞外アデノシン阻害剤およびアデノシン受容体阻害剤を用いて免疫応答および炎症を増強するための方法 |
| WO2004092171A2 (en) | 2003-04-09 | 2004-10-28 | Biogen Idec Ma Inc. | Triazolo[1,5-a]pyrimidines and pyrazolo[1,5-a]pyrimidines useful as a2a adenosin e receptor antagonists |
| ATE389652T1 (de) | 2003-05-19 | 2008-04-15 | Hoffmann La Roche | Benzothiazol-derivate als liganden des adenosinrezeptors |
| WO2005028484A1 (en) | 2003-09-19 | 2005-03-31 | F. Hoffmann-La Roche Ag | Thiazolopyridine derivatives as adenosine receptor ligands |
| JP2005154434A (ja) | 2003-11-05 | 2005-06-16 | Kyowa Hakko Kogyo Co Ltd | ２−アミノキナゾリン誘導体 |
| AU2005247567B2 (en) | 2004-05-24 | 2010-09-02 | F. Hoffmann-La Roche Ag | 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide |
| AU2005263500B2 (en) | 2004-07-22 | 2011-02-24 | F. Hoffmann-La Roche Ag | Benzothiazole derivatives |
| WO2009111442A1 (en) | 2008-03-04 | 2009-09-11 | Schering Corporation | AMINO-QUINOXALINE AND AMINO-QUINOLINE COMPOUNDS FOR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS |
-
2018
- 2018-08-20 KR KR1020207008007A patent/KR20200043434A/ko not_active Abandoned
- 2018-08-20 CN CN201880054521.1A patent/CN110944994B/zh not_active Expired - Fee Related
- 2018-08-20 SG SG11202001340VA patent/SG11202001340VA/en unknown
- 2018-08-20 WO PCT/EP2018/072397 patent/WO2019038214A1/en not_active Ceased
- 2018-08-20 JP JP2020511322A patent/JP7287951B2/ja active Active
- 2018-08-20 ES ES18753208T patent/ES2964026T3/es active Active
- 2018-08-20 US US16/640,526 patent/US11192899B2/en active Active
- 2018-08-20 CA CA3073343A patent/CA3073343A1/en active Pending
- 2018-08-20 BR BR112020003283-2A patent/BR112020003283A2/pt not_active Application Discontinuation
- 2018-08-20 EP EP18753208.0A patent/EP3672951B1/en active Active
- 2018-08-20 TW TW107128914A patent/TW201920123A/zh unknown
- 2018-08-20 DK DK18753208.0T patent/DK3672951T3/da active
- 2018-08-20 AU AU2018320672A patent/AU2018320672B2/en not_active Ceased
- 2018-08-20 IL IL272638A patent/IL272638B2/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020531531A5 (enExample) | ||
| RU2506256C2 (ru) | Лиганды для визуализации иннервации сердца | |
| JP2022524914A5 (enExample) | ||
| JP2020528922A5 (enExample) | ||
| CA2324418A1 (en) | Novel opiate compounds, methods of making and methods of use | |
| JP2019104748A5 (enExample) | ||
| RU99128073A (ru) | Замещенные 2-(2,6-диоксопиперидин-3-ил)-фталимиды и -1-оксоизоиндолины и способ снижения уровней фноа | |
| KR830007624A (ko) | 헤테로 사이클릭 화합물의 제조방법 | |
| JP2023504542A5 (enExample) | ||
| CA2457054A1 (en) | Activator of peroxisome proliferator-activated receptor .delta. | |
| RU2012143212A (ru) | Способ лечения артрита | |
| JP2002531564A5 (enExample) | ||
| IE40913B1 (en) | Substitited amides their use as fungicides | |
| DK191186A (da) | Indolderivater | |
| CA2249542A1 (en) | Pyrazole derivatives, their preparation and their use in pharmaceuticals | |
| KR870011129A (ko) | 디스타마이신 a 동족체 및 이의 제조방법 | |
| RU2008152087A (ru) | Макроциклические оксимильные ингибиторы протеазы гепатита | |
| EA200970171A1 (ru) | Производные n-(аминогетероарил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии | |
| RU2007131274A (ru) | Замещенные пиразолопиридины, композиции, содержащие их, способ получения и применение | |
| JP2004525174A5 (enExample) | ||
| RU2009125439A (ru) | Комбинация ингибитора гда и антиметаболита | |
| EP0092158A3 (en) | Thiazolidine compound and fungicidal composition containing it | |
| RU92016214A (ru) | Производные 2-имидазолин-5-онов и 2-имидазолин-5-тионов, способ их получения, фунгицидный состав на их основе и способ обработки культур | |
| MX2024008480A (es) | Compuesto heterociclico que contiene nitrogeno que tiene un efecto de activacion del factor 2 relacionado con el factor nuclear eritroide 2 (nrf2). | |
| JP2014517017A5 (ja) | 化合物、その医薬組成物、及び癌治療用の阻害薬としてのその使用 |